NewsRx

Search our medical news database

Advancis Pharmaceutical Corp.

Advancis Pharmaceutical posts net loss of $0.25 per share

Published in Lab Business Week, June 11th, 2006

Advancis Pharmaceutical Corp. (AVNC), a pharmaceutical company focused on developing and commercializing novel anti-infective products, announced financial and operational results for the quarter ended March 31, 2006.

Advancis reported first quarter 2006 revenue of $0.9 million, compared to revenue of $1.6 million in the fourth quarter of 2005 and $4.6 million in the first quarter of 2005. Advancis reported research and development (R&D) expenses in the first quarter of $7.2 million, compared to fourth quarter 2005 R&D expenses of $6.3 million and first quarter 2005 R&D expenses of $13.2 million. Total expenses for the first quarter of 2006 were $9.7 million, compared...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Lab Business Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook